VALLON PHARMACEUTICALS INC (VLON)
US92023M1018 - Common Stock
VALLON PHARMACEUTICALS INC
NASDAQ:VLON (4/21/2023, 7:04:53 PM)
After market: 0.3901 -0.01 (-2.48%)0.4
-0.06 (-13.04%)
Company Profile
Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Philadelphia, Pennsylvania and currently employs 2 full-time employees. The company went IPO on 2021-02-10. The firm is focused on the development and commercialization of novel abuse-deterrent medications for central nervous system (CNS) disorders. Its technology is designed to resist manipulation for snorting and provide barriers to injection. The Company’s lead investigational product candidate, Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), an abuse-deterrent formulation of immediate release (IR) dextroamphetamine in development for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. ADAIR is designed to deter attempts to crush and snort and provides barriers to injection. In addition to ADAIR, the Company’s second product candidate, ADMIR, an abuse deterrent formulation of methylphenidate (Ritalin), for the treatment of ADHD.
Company Info
VALLON PHARMACEUTICALS INC
Two Logan Square, 100 N. 18Th Street, Suite 300
PHILADELPHIA PENNSYLVANIA 19103
P: 12676078255.0
CEO: David Baker
Employees: 2
Website: https://www.vallon-pharma.com/
VLON News
Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer T (“NKT”) modulating therapies for the treatment of...
a year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday!
Vallon’s board approves 1-for-30 reverse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) --...
a year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for another dive into the biggest pre-market stock movers as we see what's moving the market on Thursday morning!
Board of Directors unanimously recommend Vallon stockholders to vote “FOR” all proposals outlined in the Company’s definitive Proxy Statement (the “Proxy”)...
PHILADELPHIA, PA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), today reported its...
VLON Twits
Here you can normally see the latest stock twits on VLON, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
